Rare Pattern of Myelodysplastic Syndrome (MDS) with Serum Monoclonal Immunoglobulin: Case Report
CONCLUSION: The combination of plasma cell disease and myeloid malignancy may increase mortality. This is uncommon and may be easily misdiagnosed if not detected early. When a myeloid neoplasm tests positive for MDS and serum M protein, clinicians should evaluate for other plasma cell disease.PMID:36735715 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - February 3, 2023 Category: Complementary Medicine Authors: Yating Lin Jun He Fan Li Xuezhong Gu Source Type: research
Rare Pattern of Myelodysplastic Syndrome (MDS) with Serum Monoclonal Immunoglobulin: Case Report
CONCLUSION: The combination of plasma cell disease and myeloid malignancy may increase mortality. This is uncommon and may be easily misdiagnosed if not detected early. When a myeloid neoplasm tests positive for MDS and serum M protein, clinicians should evaluate for other plasma cell disease.PMID:36735715 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - February 3, 2023 Category: Complementary Medicine Authors: Yating Lin Jun He Fan Li Xuezhong Gu Source Type: research
Rare Pattern of Myelodysplastic Syndrome (MDS) with Serum Monoclonal Immunoglobulin: Case Report
CONCLUSION: The combination of plasma cell disease and myeloid malignancy may increase mortality. This is uncommon and may be easily misdiagnosed if not detected early. When a myeloid neoplasm tests positive for MDS and serum M protein, clinicians should evaluate for other plasma cell disease.PMID:36735715 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - February 3, 2023 Category: Complementary Medicine Authors: Yating Lin Jun He Fan Li Xuezhong Gu Source Type: research
Rare Pattern of Myelodysplastic Syndrome (MDS) with Serum Monoclonal Immunoglobulin: Case Report
CONCLUSION: The combination of plasma cell disease and myeloid malignancy may increase mortality. This is uncommon and may be easily misdiagnosed if not detected early. When a myeloid neoplasm tests positive for MDS and serum M protein, clinicians should evaluate for other plasma cell disease.PMID:36735715 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - February 3, 2023 Category: Complementary Medicine Authors: Yating Lin Jun He Fan Li Xuezhong Gu Source Type: research
Rare Pattern of Myelodysplastic Syndrome (MDS) with Serum Monoclonal Immunoglobulin: Case Report
CONCLUSION: The combination of plasma cell disease and myeloid malignancy may increase mortality. This is uncommon and may be easily misdiagnosed if not detected early. When a myeloid neoplasm tests positive for MDS and serum M protein, clinicians should evaluate for other plasma cell disease.PMID:36735715 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - February 3, 2023 Category: Complementary Medicine Authors: Yating Lin Jun He Fan Li Xuezhong Gu Source Type: research
Rare Pattern of Myelodysplastic Syndrome (MDS) with Serum Monoclonal Immunoglobulin: Case Report
CONCLUSION: The combination of plasma cell disease and myeloid malignancy may increase mortality. This is uncommon and may be easily misdiagnosed if not detected early. When a myeloid neoplasm tests positive for MDS and serum M protein, clinicians should evaluate for other plasma cell disease.PMID:36735715 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - February 3, 2023 Category: Complementary Medicine Authors: Yating Lin Jun He Fan Li Xuezhong Gu Source Type: research
Genes, Vol. 14, Pages 351: Loss of Heterozygosity in the Circulating Tumor DNA and CD138+ Bone Marrow Cells in Multiple Myeloma
We examined paired samples of plasma circulating tumor DNA (ctDNA) and CD138+ bone marrow cells in MM patients. For patients with plasmacytomas (66% of 38 patients included), the STR profile of plasmacytomas was also studied when biopsy samples were available. Diverse patterns of LOH were found in lesions of different localization for most patients. LOH in plasma ctDNA, bone marrow, and plasmacytoma samples was found for 55%, 71%, and 100% of patients, respectively. One could expect a greater variety of STR profiles in aberrant loci for patients with plasmacytomas. This hypothesis was not confirmed—no differe...
Source: Genes - January 29, 2023 Category: Genetics & Stem Cells Authors: Maiia Soloveva Maksim Solovev Elena Nikulina Natalya Risinskaya Bella Biderman Igor Yakutik Tatiana Obukhova Larisa Mendeleeva Tags: Article Source Type: research
Technical aspects of total spondylectomy of C2
CONCLUSIONS: Total spondylectomy of C2 is an exceptional surgical procedure associated with risk of serious complications but offers chance for a complete recovery of the patient. Defining indications accurately, especially in solitary metastases, is very difficult even with current level of imaging and other testing. The quality of life of long-term surviving patients in our study was not significantly impacted.PMID:36705618 | DOI:10.23736/S0390-5616.21.05443-6 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - January 27, 2023 Category: Neurosurgery Authors: Jan Stulik Zdenek Klezl Michal Varga Tomas Vyskocil Source Type: research
Solitary hyoid plasmacytoma with unicentric Castleman disease: A case report and review of literature
CONCLUSION: The diagnostic process and differential diagnosis of this rare case provided valuable educational information to clinicians.PMID:36683640 | PMC:PMC9850993 | DOI:10.12998/wjcc.v10.i36.13364 (Source: Clinical Lymphoma and Myeloma)
Source: Clinical Lymphoma and Myeloma - January 23, 2023 Category: Cancer & Oncology Authors: Yan-Hui Zhang Yi-Feng He Hao Yue Yue-Ni Zhang Lei Shi Bin Jin Pin Dong Source Type: research
Long non-coding RNA PVT1 promotes the proliferation, migration and EMT process of ovarian cancer cells by regulating CTGF
In conclusion, lncRNA PVT1 promotes the proliferation, migration, invasiveness and EMT process of ovarian cancer cells, and CTGF contributes to the effect of lncRNA PVT1.PMID:36688109 | PMC:PMC9843302 | DOI:10.3892/ol.2022.13657 (Source: Cancer Control)
Source: Cancer Control - January 23, 2023 Category: Cancer & Oncology Authors: Lingling Dong Huan Wang Yun Gao Shuai Wang Weibo Wang Source Type: research
Long non-coding RNA PVT1 promotes the proliferation, migration and EMT process of ovarian cancer cells by regulating CTGF
In conclusion, lncRNA PVT1 promotes the proliferation, migration, invasiveness and EMT process of ovarian cancer cells, and CTGF contributes to the effect of lncRNA PVT1.PMID:36688109 | PMC:PMC9843302 | DOI:10.3892/ol.2022.13657 (Source: Oncology Letters)
Source: Oncology Letters - January 23, 2023 Category: Cancer & Oncology Authors: Lingling Dong Huan Wang Yun Gao Shuai Wang Weibo Wang Source Type: research
Solitary hyoid plasmacytoma with unicentric Castleman disease: A case report and review of literature
CONCLUSION: The diagnostic process and differential diagnosis of this rare case provided valuable educational information to clinicians.PMID:36683640 | PMC:PMC9850993 | DOI:10.12998/wjcc.v10.i36.13364 (Source: Clinical Lymphoma and Myeloma)
Source: Clinical Lymphoma and Myeloma - January 23, 2023 Category: Cancer & Oncology Authors: Yan-Hui Zhang Yi-Feng He Hao Yue Yue-Ni Zhang Lei Shi Bin Jin Pin Dong Source Type: research
